Last ¥1,263 JPY
Change Today +6.00 / 0.48%
Volume 53.2K
4548 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

seikagaku corp (4548) Snapshot

Open
¥1,257
Previous Close
¥1,257
Day High
¥1,263
Day Low
¥1,245
52 Week High
01/20/14 - ¥1,641
52 Week Low
06/7/13 - ¥1,135
Market Cap
74.0B
Average Volume 10 Days
81.4K
EPS TTM
¥87.03
Shares Outstanding
58.6M
EX-Date
03/27/14
P/E TM
14.5x
Dividend
¥26.00
Dividend Yield
2.06%
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan, North America, and internationally. It offers pharmaceuticals and medical devices, such as intra-articular injections for improving joint functions under the ARTZ and ARTZ Dispo brands; Gel-One branded cross-linked hyaluronate hydrogel for knee osteoarthritis; OPEGAN branded ophthalmic surgical aids; and MucoUp branded surgical aid for endoscopic mucosal resection. The company also provides bulk products consisting of hyaluronic acid, which is primarily used as a raw material of joint function improving agents, ophthalmic surgical aids, and ophthalmic products (eye drops); and chondroitin sulfate that is used as a raw material in ophthalmic products (eye drops and eyewashes) and drinks for nutritional fortifications, etc. In addition, it develops endotoxin-detecting reagents under various brands, including the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. for quality control in the manufacturing process and release test of pharmaceuticals and medical devices. Further, Seikagaku Corporation develops and markets oral care products comprising oral care mouthwash under the KINUSUI Spray brand. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

641 Employees
Last Reported Date: 06/20/13
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp (4548) Key Developments

Seikagaku Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2013; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2014

Seikagaku Corporation reported consolidated earnings results for the nine months ended December 31, 2013. The company reported net sales of ¥23,122 million compared with ¥20,655 million for the same period last year. Operating income was ¥4,975 million compared with ¥2,969 million for the same period last year. Ordinary income was ¥5,723 million compared with ¥3,881 million for the same period last year. Net income was ¥4,652 million or ¥56.9 per share compared with ¥2,965 million or ¥8.7 per share for the same period last year. The sales increase is attributable to higher sales volumes of Gel-One, a single-injection injectable treatment for osteoarthritis pain of the knee, and the impact of yen depreciation. Ordinary income rose 47.4% reflecting profit-impacting factors such as decreases in royalty income and increases in gain on foreign exchange valuation of foreign currency-denominated financial assets and securities. For the fiscal year ending March 31, 2014, the company expects net sales of ¥30,200 million, operating income of ¥4,800 million, ordinary income of ¥5,500 million and net income of ¥4,450 million or ¥78.34 per share.

Seikagaku Corp. to Report Q3, 2014 Results on Feb 04, 2014

Seikagaku Corp. announced that they will report Q3, 2014 results at 3:00 PM, Tokyo Standard Time on Feb 04, 2014

Seikagaku Corporation Reports Earnings Results for the Six Months Ended September 30, 2013; Provides Earnings Outlook for the Fiscal 2013

Seikagaku Corporation reported earnings results for the six months ended September 30, 2013. The company reported that net income for the six months ended September 30, 2013 was JPY 3.12 billion, or JPY 54.90 per share, compared to JPY 1.27 billion, or JPY 22.29 per share, for the same period ended September 30, 2012. Net sales for the six months ended September 30, 2013 were JPY 15.40 billion, compared to JPY 13.24 billion for the same period ended September 30, 2012. Operating income for the six months ended September 30, 2013 was JPY 3.49 billion, compared to JPY 1.32 billion for the same period ended September 30, 2012. Ordinary income for the six months ended September 30, 2013 was JPY 3.78 billion, compared to JPY 1.78 billion for the same period ended September 30, 2012. For fiscal 2013, the company expects net sales to be JPY 30.2 billion and net income to be JPY 4.45 billion, or JPY 78.34 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4548:JP ¥1,263.00 JPY +6.00

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Zimmer Holdings Inc $90.99 USD -0.58
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.